Literature DB >> 26588253

Hypertrophic Olivary Degeneration: A Neurosurgical Point of View.

Carlos Henrique Carvalho1, Hubert Kimmig2, William Omar Contreras Lopez3, Manfred Lange1, Reinhard Oeckler1.   

Abstract

Hypertrophic olivary degeneration (HOD) is a rare form of transsynaptic degeneration characterized by hypertrophy of the inferior olivary nucleus situated in the olivary body, part of the medulla oblongata, representing a major source of input to the cerebellum. HOD typically results from focal lesions interrupting connections from the inferior olive within the dentato-rubro-olivary pathway, a region also known as the triangle of Guillain-Mollaret (TGM) (red nucleus, inferior olivary nucleus, and contralateral dentate nucleus). Clinically, HOD presents classically as palatal tremor and can include dentatorubral tremor and/or ocular myoclonus. The pathologic changes associated with HOD feature radiologic changes with the inferior olivary nucleus appearing larger and increasing its T2-weighted signal intensity on magnetic resonance images. HOD is commonly managed with pharmacotherapy but may require surgical intervention in extreme cases. HOD has been found to develop as a consequence of any injury that disrupts the TGM pathways (e.g., pontine cavernoma).These findings highlight the critical importance of a thorough knowledge of TGM anatomy to avoid secondary HOD. We present a patient who developed HOD secondary to resection of a tectal plate cavernous malformation and review the literature with an emphasis on the current knowledge of this disorder. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26588253     DOI: 10.1055/s-0035-1566114

Source DB:  PubMed          Journal:  J Neurol Surg A Cent Eur Neurosurg        ISSN: 2193-6315            Impact factor:   1.268


  1 in total

Review 1.  Hypertrophic olivary degeneration in children after posterior fossa surgery. An underdiagnosed condition.

Authors:  Matheus Fernando Manzolli Ballestero; Dinark Conceição Viana; Thiago Lyrio Teixeira; Marcelo Volpon Santos; Ricardo Santos de Oliveira
Journal:  Childs Nerv Syst       Date:  2017-12-26       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.